Sex hormones and systemic lupus erythematosus: Review and meta-analysis

Arthritis and Rheumatism

Volumn 48, Issue 8, 2003, Pages 2100-2110

  McMurray, Robert W ^a,b   May, Warren ^b  

^a GV (Sonny) Montgomery Veterans Administration Medical Center   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; SEX HORMONE; TESTOSTERONE;

DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; INCIDENCE; LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TESTOSTERONE BLOOD LEVEL;

FEMALE; GONADAL STEROID HORMONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MODELS, STATISTICAL;

EID: 0042574010     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11105     Document Type: Review

References (99)

1. Hochberg M. Epidemiology of systemic lupus erythematosus. In: Lahita RG, editor. Systemic lupus erythematosus. 2nd ed. New York: Churchill Livingstone; 1992. p. 103-17.
2. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002;16:847-58.
3. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999;283:1277-8.
4. Wizemann TM, Pardue ML, editors. Exploring the biological contributions to human health: does sex matter? Committee on Understanding the Biology of Sex and Gender Differences, Institute of Medicine. Washington DC: National Academies Press; 2001. p. 13-27, 117-72, 233-8.
5. Rose E, Pillsbury DM. Lupus erythematosus (erythematodes) and ovarian function: observations on a possible relationship and report of six cases. Ann Intern Med 1944;21:1022-34.
6. Lahita RG. Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am 2000;26:951-68.
7. McMurray RW. Sex hormones in the pathogenesis of systemic lupus erythematosus. Front Biosci 2001;6:E193-206.
8. Walker SE, Jacobson JD. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin North Am 2000;26:713-36.
9. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocrine Rev 1996;17:369-84.
10. Sturgess AD, Evans DT, Mackay IR, Riglar A. Effects of the oestrogen antagonist tamoxifen on disease indices in systemic lupus erythematosus. J Clin Lab Immunol 1984;13:11-4.
11. Lahita RG, Cheng CY, Monder C, Bardin CW. Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women. J Rheumatol 1992;19:547-55.
12. Van Vollenhoven RF, McGuire JL. Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases? Cleve Clin J Med 1994;61:276-84.
13. Lahita RG. Sex, age, and systemic lupus erythematosus. In: Lahita RG, editor. Systemic lupus erythematosus. 2nd ed. New York: Churchill Livingstone; 1992. p. 531-42.
14. Wilson JD, Foster DW. Williams textbook of endocrinology. 8th ed. Philadelphia: WB Saunders; 1992.
15. Petri M, Robinson C. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 1997;40:797-803.
16. Buyon JP. Oral contraceptives in women with systemic lupus erythematosus. Ann Med Interne (Paris) 1996;147:259-64.
17. Yang LY, Huang WJ, Chen WP, Fu LW, Lin CY. Does parenteral oestrogen therapy flare up disease activity in patients with systemic lupus erythematosus complicated by haemorrhagic cystitis? Rheumatology (Oxford) 1999;38:372-3.
18. Barrett C, Neylon N, Snaith ML. Oestrogen-induced systemic lupus erythematosus. Br J Rheumatol 1986;25:300-1.
19. Ben-Chetrit A, Ben-Chetrit E. Systemic lupus erythematosus induced by ovulation induction treatment. Arthritis Rheum 1994;37:1614-7.
20. Casoli P, Tumiati B, La Sala G. Fatal exacerbation of SLE after induction of ovulation. J Rheumatol 1997;24:1639-40.
21. Mok CC, Wong RW, Lau CS. Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum 1999;42:1274-80.
22. Yung RL. Mechanisms of lupus: the role of estrogens. Clin Exp Rheumatol 1999;17:271-5.
23. Lahita RG, Bradlow HL. Klinefelter's syndrome: hormone metabolism in hypogonadal males with systemic lupus erythematosus. J Rheumatol 1987;14 Suppl 13:154-7.
24. Olsen NJ, Kovacs WJ. Case report: testosterone treatment of systemic lupus erythematosus in a patient with Klinefelter's syndrome. Am J Med Sci 1995;310:158-60.
25. Bizzarro A, Valentini G, Di Martino G, DaPonte A, De Bellis A, Iacono G. Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J Clin Endocrinol Metab 1987;64:32-6.
26. McMurray RW. Steroid hormones in lupus pregnancy: in control? Arthritis Rheum 2002;47:116-7.
27. Khamasha MA, Ruiz-Irastorza G, Hughes GRV. Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 1997;23:15-30.
28. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy: the Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991;34:1538-45.
29. Vennemann F, Tholen S. [Sex hormones in lupus erythematosus]. Z Hautkr 1986;61:791-9.
30. Jungers P, Nahoul K, Pelissier C, Dougados M, Athea N, Tron F, et al. [A study of plasma androgen levels in women with systemic lupus erythematosus]. French Presse Med 1983;12:685-8.
31. Feher KG, Bencze G, Ujfalussy J, Feher T. Serum steroid hormone levels in systemic lupus erythematosus (SLE). Acta Med Hung 1987;44:321-7.
32. Lahita RG, Bradlow HL, Ginzler E, Pang S, New M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987;30:241-8.
33. Arnalich F, Benito-Urbina S, Gonzalez-Gancedo P, Iglesias E, de Miguel E, Gijon-Banos J. Inadequate production of progesterone in women with systemic lupus erythematosus. Br J Rheumatol 1992;31:247-51.
34. Folomeev M, Dougados M, Beaune J, Kouyoumdjian JC, Nahoul K, Amor B, et al. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1992;1:191-5.
35. Cheng W, Li LS. Blood levels of sex hormone in lupus nephritis and their relationship to lupus activity. Chin Med J (Engl) 1993;106:49-52.
36. Munoz JA, Gil A, Lopez-Dupla JM, Vazquez JJ, Gonzalez-Gancedo P. Sex hormones in chronic systemic lupus erythematosus: correlation with clinical and biological parameters. Ann Med Interne (Paris) 1994;145:459-63.
37. Verthelyi D, Petri M, Ylamus M, Klinman DM. Disassociation of sex hormone levels and cytokine production in SLE patients. Lupus 2001;10:352-8.
38. Mackworth-Young CG, Parke AL, Morley KD, Fotherby K, Hughes GR. Sex hormones in male patients with systemic lupus erythematosus: a comparison with other disease groups. Eur J Rheumatol Inflamm 1983;6:228-32.
39. Miller MH, Urowitz MB, Gladman DD, Killinger DW. Systemic lupus erythematosus in males. Medicine (Baltimore) 1983;62:327-34.
40. Carrabba M, Giovine C, Chevallard M, Angelini M, Ambrosi B, Travaglini P. Abnormalities of sex hormones in men with systemic lupus erythematosus. Clin Rheumatol 1985;4:420-5.
41. Lavalle C, Loyo E, Paniagua R, Bermudez JA, Herrera J, Graef A, et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987;14:268-72.
42. Sequeira JF, Keser G, Greenstein B, Wheeler MJ, Duarte PC, Khamashta MA, et al. Systemic lupus erythematosus: sex hormones in male patients. Lupus 1993;2:315-7.
43. Chang DM, Chang CC, Kuo SY, Chu SJ, Chang ML. Hormonal profiles and immunological studies of male lupus in Taiwan. Clin Rheumatol 1999;18:158-62.
44. Vilarinho ST, Costallat LT. Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus. J Rheumatol 1998;25:1097-103.
45. Mok CC, Lau CS. Profile of sex hormones in male patients with systemic lupus erythematosus. Lupus 2000;9:252-7.
46. Inman RD, Jovanovic L, Markenson JA, Longcope C, Dawood MY, Lockshin MD. Systemic lupus erythematosus in men: genetic and endocrine features. Arch Intern Med 1982;142:1813-5.
47. Inman RD. Systemic lupus erythematosus in the male: a genetic and endocrine study [abstract]. Arthritis Rheum 1979;22:624.
48. Holister AS, Inagami T. Atrial natriuretic factor and hypertension: a review and metaanalysis. Am J Hypertension 1991;4:850-65.
49. Hedges LV, Olkin I. Statistical methods for meta-analysis. New York: Academic Press; 1985.
50. Wang MC, Bushman BJ. Integrating results through meta-analytic review using SAS Software. Cary (NC): SAS Institute; 1999.
51. Lahita RG, Bradlow HL, Fishman J, Kunkel HG. Abnormal estrogen and androgen metabolism in the human with systemic lupus erythematosus. Am J Kidney Dis 1982;2(1 Suppl 1):206-11.
52. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Alterations of estrogen metabolism in SLE. Arthritis Rheum 1979;22:1195-2001.
53. Lahita RG, Kunkel HG, Bradlow HL. Increased oxidation of testosterone in systemic lupus erythematosus. Arthritis Rheum 1983;26:1517-21.
54. Spangelo BL, Judd AN, Isakson PC, MacLeod RN. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 1989;125:575-7.
55. Yamaguchi M, Koike K, Matsuzaki N, Yoshimoto Y, Taniguchi T, Miyake A, et al. The interferon family stimulates the secretion of prolactin and interleukin-6 by the pituitary gland in vitro. J Endocrinol Invest 1991;14:457-61.
56. Karanth S, McCann SM. Anterior pituitary hormone control by interleukin-2. Proc Natl Acad Sci U S A 1991;88:2961-5.
57. Elbourne KB, Keisler D, McMurray RW. Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus. Lupus 1998;7:420-7.
58. Jara-Quezada L, Graef A, Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 1991;18:349-53.
59. Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A, et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum (Arthritis Care Res) 2002;47:202-9.
60. Jungers P, Nahoul K, Pelissier C, Dougados M, Tron F, Bach JF. Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 1982;25:454-7.
61. Stahl NI, Decker JL. Androgenic status of males with systemic lupus erythematosus. Arthritis Rheum 1978;21:665-8.
62. James WH. Is hypoandrogenism a cause or a consequence of systemic lupus erythematosus in mate patients? [letter] Lupus 2000;9:646.
63. Chang DM, Lan JL, Lin HY, Luo SF. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002;46:2924-7.
64. Van Vollenhoven RF, Engleman DG, McGuire JL. Dehydroepiandrosterone in systemic lupus erythematosus: results of a double-blind, placebo-controlled, randomized clinical trial. Arthritis Rheum 1995;38:1826-31.
65. Barry NN, McGuire JL, van Vollenhoven RF. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response. J Rheumatol 1998;25:2352-6.
66. Van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. J Rheumatol 1998;25:285-9.
67. Lahita RG. DHEA and lupus. Paper presented at: Sixth International Lupus Conference; March 24-28, 2001; Barcelona, Spain.
68. Pando JA, Gourley MF, Wilder RL, Crofford LJ. Hormonal supplementation as treatment for cyclical rashes in patients with systemic lupus erythematosus. J Rheumatol 1995;22:2159-62.
69. Frantz AG. Prolactin. N Engl J Med 1978;298:201-6.
70. Franks S. Regulation of prolactin secretion by oestrogens: physiological and pathological significance. Clin Sci 1983;65:457-62.
71. Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 1992;303:222-6.
72. Neidhart M. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1996;23:476-81.
73. Huang CM, Chou CT. Hyperprolactinemia in systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi (Taipei) 1997;59:37-41.
74. Ferreira C, Paes M, Gouveia A, Ferreira E, Padua F, Fiuza T. Plasma homovanillic acid and prolactin in systemic lupus erythematosus. Lupus 1998;7:392-7.
75. Gutierrez MA, Garcia ME, Rodriguez JA, Rivero S, Jacobelli S. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus 1998;7:404-8.
76. Jimena P, Aguirre MA, Lopez-Curbelo A, de Andres M, Garcia-Courtay C, Cuadrado MJ. Prolactin levels in patients with systemic lupus erythematosus: a case controlled study. Lupus 1998;7:383-6.
77. Rovensky J, Jurankova E, Rauova L, Blazickova S, Lukac J, Veselkova Z, et al. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus. J Rheumatol 1997;24:2330-4.
78. Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 2001;10:554-61.
79. Mok CC, Lau CS, Tam SCF. Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients. Br J Rheumatol 1997;36:986-9.
80. Mok CC, Lau CS, Lee KW, Wong RW. Hyperprolactinemia in males with systemic lupus erythematosus. J Rheumatol 1998;25:2357-63.
81. Mok CC, Lau CS. Profile of sex hormones in male patients with systemic lupus erythematosus. Lupus 2000;9:252-7.
82. Pauzner R, Urowitz MB, Gladman DD, Gough JM. Prolactin in systemic lupus erythematosus. J Rheumatol 1994;21:2064-7.
83. Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996;23:629-32.
84. Formiga F, Nolla JM, Mitjavila F, Bonnin R, Navarro MA, Moga I. Bone mineral density and hormonal status in men with systemic lupus erythematosus. Lupus 1996;5:623-6.
85. Ostendorf B, Fischer R, Santen R, Schmitz-Linneweber B, Specker C, Schneider M. Hyperprolactinemia in systemic lupus erythematosus? Scand J Rheumatol 1996;25:97-102.
86. Leanos-Miranda A, Pascoe-Lira D, Chavez-Rueda KA, Blanco-Favela F. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. J Rheumatol 2001;28:1546-53.
87. Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R. Elevated bioactive prolactin levels in systemic lupus erythematosus: association with disease activity. J Rheumatol 2001;28:2216-21.
88. Batrinos ML, Panitsa-Faflia C, Tsiganou E, Liapi C. Incidence and characteristics of microprolactinomas (3-5 mm) in 4199 women assayed for prolactin. Horm Metab Res 1992;8:384-91.
89. Walker SE, McMurray RW, Houri JM, Allen SH, Keisler D, Sharp GC, et al. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann NY Acad Sci 1998;840:762-72.
90. Funauchi M, Ikoma S, Enomoto H, Sugiyama M, Ohno M, Hamada K, et al. Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma. Clin Exp Rheumatol 1998;16:479-82.
91. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol 1994;21:843-50.
92. Petri M, Chan D. Longitudinal analysis of prolactin and disease activity in SLE pregnancy. Arthritis Rheum 1995;38 Suppl 9:S220.
93. Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Munoz J, Miranda JM, Jara LJ, et al. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus 1998;7:414-9.
94. Walker SE, Reddy GH, Miller D, Yangco D, Kalanje S, Abdou NI, et al. Treatment of active systemic lupus erythematosus (SLE) with the prolactin (PRL) lowering drug, bromocriptine (BC): comparison with hydroxychloroquine (HC) in a randomized, blinded one-year study. Arthritis Rheum 1999;42 Suppl 9:S282.
95. Seppala M, Unnerus HA, Hirvonen E, Ranta T. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin. J Clin Endocrinol Metab 1976;43:474-7.
96. Martikainen H, Ronnberg L, Puistola U, Tapanainen J, Orava M, Kauppila A. Prolactin suppression by bromocriptine stimulates aromatization of testosterone to estradiol in women. Fertil Steril 1989;52:51-4.
97. Brennan P, Hajeer A, Ong KR, Worthington J, John S, Thomson W. Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1997;40:1383-6.
98. Gutierrez MA, Molina JF, Jara LJ, Cuellar ML, Garcia C, Gutierrez-Urena S, et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus 1995;4:348-52.
99. Nagafuchi H, Suzuki N, Kaneko A, Asai T, Sakane T. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 1999;26:1890-900.